The advertisement promotes JEVTANA (cabazitaxel) as a treatment for metastatic castration-resistant prostate cancer (mCRPC), highlighting its recommendation by the National Comprehensive Cancer Network (NCCN) and providing indications and safety information.
Creative Information
| CID: | 7ac45aa3-279a-403c-8830-d393af8ec39e |
| CRID: | 29_636012409 |
| Domain: | sanofi.us |
| Seat: | Xandr |
| Size: | 728x90 |
| Bid: | $10.62 |
| Timestamp: | 11/13/2025, 3:31:19 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/13/2025, 5:42:06 PM | 5.50s | |
| adomain_analysis | success | 11/13/2025, 6:58:34 PM | 7.90s | |
| adomain_capture | success | 11/13/2025, 6:58:25 PM | 0.18s | |
| ad_render | success | 11/13/2025, 5:42:00 PM | 24.53s | |
| brand_mapping | success | 11/13/2025, 3:31:21 PM | 1.02s | |
Analysis Results
Ad Format: banner
Brands: Sanofi
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 923.69 KB | ||||||||||||||||||||||
| Render Time: | 9.05 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 923.78 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


